Skip to main content

Table 2 Patients’ characteristics and afamin concentrations in the first-trimester cohort study of patients with diagnosis of gestational diabetes mellitus (GDM) later in pregnancy

From: Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study

Parameter

Gestational diabetes mellitus treated with dietary intervention (dGDM)

n = 25

Gestational diabetes mellitus treated with insulin (iGDM)

n = 34

p-value

Maternal age (years)

 Mean (± standard deviation, SD)

33.60 (6.37)

34.91 (4.29)

0.50

 Median (Interquartile range, IQR)

36.00 (28.50–37.25)

36.00 (32.00–39.00)

Body-mass-index (kg/m2)

 Mean (± SD)

26.19 (5.98)

32.78 (8.23)

0.002

 Median (IQR)

24.85 (22.10–30.80)

29.50 (27.90–37.40)

Afamin (mg/l)

 Mean (± SD)

91.33 (21.43)

133.20 (25.87)

< 0.001

 Median (IQR)

86.99 (75.88–100.94)

140.18 (118.20–154.70)

Newborn weight (gram)

 Mean (± SD)

3376 (709)

2985 (711)

0.008

 Median (IQR)

3510 (3165–3680)

3105 (2768–3453)

Gestational age at parturition (days)

 Mean (± SD)

269 (20)

264 (21)

0.25

 Median (IQR)

277 (266–281)

272 (251–280)